← Back to Search

Other

Air Filtration for COPD

N/A
Waitlist Available
Led By Mohammad Heidarinejad, PhD
Research Sponsored by Illinois Institute of Technology
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, an average of 1 year

Summary

This trial will investigate if air filters can improve air quality & COPD outcomes for veterans in high-risk urban settings. It'll also look at housing factors, sensors & costs/benefits.

Who is the study for?
This trial is for U.S. military veterans aged 18 and older who have COPD, live in Chicago, can consent, speak English, have stable housing for over 6 months, can communicate by phone, are fully vaccinated against COVID-19 and receive care at JBVAMC. Those with a life expectancy under 6 months or hazardous home conditions cannot join.
What is being tested?
The study tests if stand-alone air filters improve indoor air quality and health outcomes for veterans with COPD. It also examines housing factors affecting COPD exacerbation, the use of low-cost sensors to monitor indoor pollution, and the cost-effectiveness of using air filters.
What are the potential side effects?
Since this trial involves using an air cleaner rather than medication or invasive procedures, there are no direct side effects expected from the intervention itself.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, an average of 1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, an average of 1 year for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
COPD exacerbations
Secondary study objectives
6MWD
ED visits
Health related quality of life
+4 more

Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: InterventionActive Control1 Intervention
an air cleaner with HEPA and carbon filter installed
Group II: PlaceboPlacebo Group1 Intervention
an air cleaner with the primary filter removed

Find a Location

Who is running the clinical trial?

ElevateUNKNOWN
1 Previous Clinical Trials
51 Total Patients Enrolled
1 Trials studying Asthma
51 Patients Enrolled for Asthma
Jesse Brown VA Medical CenterFED
7 Previous Clinical Trials
1,772 Total Patients Enrolled
US Department of Housing and Urban DevelopmentFED
7 Previous Clinical Trials
5,719 Total Patients Enrolled
1 Trials studying Asthma
200 Patients Enrolled for Asthma

Media Library

Air cleaner (Other) Clinical Trial Eligibility Overview. Trial Name: NCT05913765 — N/A
Asthma Research Study Groups: Intervention, Placebo
Asthma Clinical Trial 2023: Air cleaner Highlights & Side Effects. Trial Name: NCT05913765 — N/A
Air cleaner (Other) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05913765 — N/A
~25 spots leftby Oct 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top